Use Of GW274150 In The Prophylactic Treatment Of Migraine

Clinical trial NCT00242866 · COMPLETED

Trial details

NCT number: NCT00242866
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2005-10-01
Primary completion: 2007-09-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.